Annual General Meeting for
The Annual General Meeting approved the groups income statements and balance sheets and discharged the members of the board and CEO from liability for the financial year of 2022.
The Annual General Meeting resolved on a dividend of
The Annual General Meeting approved the Board of Directors remuneration report for 2022.
The Annual General Meeting resolved, according to the proposition from Nomination Committee, that remuneration to the board and committees shall be
It was resolved, for the period until the end of the next Annual General Meeting, re-election of
In accordance with the proposition from Nomination Committee, the Annual General Meeting re-elected
It was resolved to authorise the Board of Directors to, at one or several occasions until the next Annual General Meeting, issue, with or without preferential rights for the shareholders, against payment in cash, payment in kind or payment through set-off, shares or share warrants or convertibles referring to such shares, signifying an increase or potential increase of the company's share capital with a maximum of ten per cent or 2,190,934 shares. The purpose of the authorisation and the reasons for a possible deviation from the shareholders' preferential rights is that new issues of shares shall be able to occur to finance acquisitions of companies, to raise capital, or to finance further growth in the company in other ways.
The Annual General Meeting resolved to authorise the Board of Directors to, at one or several occasions until the next Annual General Meeting, decide on acquisition of own shares in the share class that, at the time of the utilisation of the authorisation, are admitted to trading on Nasdaq Stockholm.
Acquisitions of shares in the company may be carried out on Nasdaq Stockholm. The number of shares that may be acquired shall not exceed a number implying that the company's total shareholding of own shares after acquisition corresponds to more than one tenth of all shares in the company at any time. The purpose of the proposed authorisation to acquire own shares is to enable an improvement of the company's capital structure and to give the Board of Directors an increased scope of action, including to be able to use own shares as payment in connection with the acquisition of companies.
The Annual General Meeting decided to authorise the Board of Directors to, at one or several occasions until the next Annual General Meeting, resolve on transfers of own shares in the share class that, at the time of the utilisation of the authorisation, are admitted to trading on Nasdaq Stockholm and on terms further set out in the proposition. Transfers of own shares may be made with deviation from the preferential rights of the shareholders. The purpose of the authorisation to transfer own shares and the reason for the deviation from the shareholders' preferential rights is to enable an improvement of the company's capital structure and to give the Board of Directors an increased scope of action in relation to future acquisitions by facilitating a fast and cost-effective financing through the disposition of own shares.
It was resolved by the Annual General Meeting to implement an incentive program in the Company to current and future senior executives in the Company and, where applicable, its subsidiaries by A) issuing warrants to the wholly-owned subsidiary
The Annual General Meeting resolved to approve that the
The purpose of the incentive program is to create conditions for retaining and recruiting competent staff for the group, provide competitive compensation and align the interests of the participants with those of the shareholders as well as promote own shareholding in the company and thereby promote shareholder value and the company's creation of long-term value.
For more information, please contact:
Michael Grindborn
CFO and Head of IR
+46 70 670 18 48
michael.grindborn@balco.se
https://news.cision.com/balco-group-ab/r/bulletin-from-balco-group-s-annual-general-meeting-2023,c3766937
https://mb.cision.com/Main/16052/3766937/2046519.pdf
(c) 2023 Cision. All rights reserved., source